Canine Arthritis Treatment Market Report 2025 (Global Edition)

Global Canine Arthritis Treatment Market Report 2025 Market Size Split by Type (Surgery, Drugs, Others), by Route of Administration (Oral, Parenteral, Others), by Treatment (Non-steroidal anti-inflamm...

Canine Arthritis Treatment Market Report Description

We have various report editions of Canine Arthritis Treatment Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Canine Arthritis Treatment Market Insights Video

Competitive Landscape of the Canine Arthritis Treatment Market

The global canine arthritis treatment market features a competitive landscape with key players. The company focuses on innovative treatments, strategic partnerships, and extensive R&D to address the growing prevalence of canine arthritis. A continuous emphasis on product development, marketing initiatives, and expanding distribution networks marks the competition. As the demand for effective arthritis treatments for dogs rises, companies are actively engaging in research and collaborations to gain a competitive edge, contributing to the overall dynamism of the market.

Canine Arthritis Treatment Industry News

• In September 2020, The Committee for Medicinal Products for Veterinary Use (CVMP) granted Zoetis a variation in terms of marketing authorization for the veterinary medicinal product Cytopoint, which involves adding a new therapeutic indication for the treatment of pruritus associated with allergic dermatitis in dogs.

(Source: www.ncbi.nlm.nih.gov/pmc/articles/PMC9343842/)

Top Companies Market Share in Canine Arthritis Treatment Industry: (In no particular order of Rank)

• BoehringerIngelheim International GmbH.
• DAIICHI SANKYO COMPANY LIMITED
• Thorne
• NUTRI-VET
• American Regent Inc.
• DSM
• Zoetis
• National hog farmer
• Novasep
• Bayer AG
• Matsun Nutrition
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North American Canine Arthritis Treatment Market share was 40% of the total market

According to Cognitive Market Research, North America dominated the market in 2023. It accounted for around 40% of the global revenue due to the market dominance attributed to a substantial pet population, increased awareness of pet health, and a high prevalence of arthritis in dogs. The Region witnesses significant investments in veterinary healthcare, advanced treatment options, and a favorable regulatory environment.

Meanwhile, Europe experiences rapid growth due to the rising adoption of pets, especially dogs, an increasing focus on pet well-being, and advancements in veterinary medicine. The demand for canine arthritis treatment in Europe is bolstered by a proactive approach to pet healthcare, leading to an expanding market share.

The current report Scope analyzes Canine Arthritis Treatment Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Canine Arthritis Treatment Market Analysis

According to Cognitive Market Research, the global Canine Arthritis Treatment market size was estimated at USD 2685.2 Million, out of which North America is the major market with more than 40% of the global revenue with a market size of USD 1074.08 million in 2023 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. due to the surge in pet ownership and an aging canine population. Overview-wise, the Region's strong focus on pet healthcare and wellness contributes to market expansion. The dominating segment includes pharmaceutical treatments such as non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying osteoarthritis drugs (DMOADs), addressing arthritis symptoms in dogs effectively. As pet owners prioritize their furry companions' well-being, the market for canine arthritis treatment continues to thrive. In conclusion, the North American canine arthritis treatment market reflects the Region's commitment to advanced veterinary care. The dominating segment underscores the importance of pharmaceutical interventions, presenting growth opportunities for companies catering to the rising demand for canine arthritis solutions.

• According to Cognitive Market Research, the U.S. had a major share in the Canine Arthritis Treatment market, with a market size of USD 847.45 million in 2023, projected to grow at a CAGR of 2.5% during the forecast period. This is due to the growing pet ownership trend, increased awareness about pet health, advancements in veterinary medicine, and a rising senior pet population. 
• The Canada Canine Arthritis Treatment market had a market share of USD 128.89 million in 2023 and is projected to grow at a CAGR of 3.5% during the forecast period. This is due to an aging pet population, increased awareness of pet health, and a growing demand for effective arthritis management solutions, contributing to market growth in the veterinary care sector. 
• The Mexico Canine Arthritis Treatment market is projected to grow at a CAGR of 3.2% during the forecast period, with a market size of USD 97.74 million in 2023.

Europe Canine Arthritis Treatment Market Analysis

According to Cognitive Market Research, with a market value of USD 2685.2million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 3.0% from 2023 to 2030, Europe accounted for a share of over 30% of the global market size of USD 805.56 million due to rising pet ownership and awareness of companion animal health. The dominating segment includes pharmaceuticals and nutraceuticals formulated to manage dog arthritis symptoms, reflecting a trend toward holistic pet care. The European market's overview indicates a surge in veterinary healthcare expenditures and advancements in treatment options. As pet owners prioritize their animals' well-being, the demand for effective arthritis treatments escalates. In conclusion, the European canine arthritis treatment market underscores the importance of comprehensive veterinary care, with pharmaceuticals and nutraceuticals emerging as pivotal solutions, presenting substantial growth prospects for manufacturers catering to the Region's evolving preferences in pet healthcare.

• According to Cognitive Market Research, the German Canine Arthritis Treatment market was valued at USD 159.50 million in 2023 and is projected to grow at a CAGR of 3.2% during the forecast period. This is due to a heightened awareness of pet health, an aging pet population, and advancements in veterinary care. Increased pet ownership and a focus on animal well-being contribute to market growth. 
• The United Kingdom Canine Arthritis Treatment market had a market share of USD 135.33 million in 2023 and is projected to grow at a CAGR of 3.8% during the forecast period. This is due to a rising pet ownership culture, increasing awareness of pet health, advancements in veterinary medicine, and a growing aging pet population. 
• The France Canine Arthritis Treatment market is projected to grow at a CAGR of 2.2% during the forecast period, with a market size of USD 74.11 million in 2023.
• The ItalyCanine Arthritis Treatment market is projected to grow at a CAGR of 2.4% during the forecast period, with a market size of USD 69.28 million in 2023.
• The Russian Canine Arthritis Treatment market is projected to grow at a CAGR of 2.0% during the forecast period, with a market size of USD 124.86 million in 2023.
• The Spain Canine Arthritis Treatment market is projected to grow at a CAGR of 2.1% during the forecast period, with a market size of USD 66.06 million in 2023.
• The Portugal Canine Arthritis Treatment market is projected to grow at a CAGR of 2.8% during the forecast period, with a market size of USD 16.92 million in 2023.
• The Luxembourg Canine Arthritis Treatment market is projected to grow at a CAGR of 3.1% during the forecast period, with a market size of USD 24.97 million in 2023.
• The Greece Canine Arthritis Treatment market is projected to grow at a CAGR of 3.3% during the forecast period, with a market size of USD 9.67 million in 2023.
• The Rest of Europe's Canine Arthritis Treatment market is projected to grow at a CAGR of 1.7% during the forecast period, with a market size of USD 124.86 million in 2023.

Asia Pacific Canine Arthritis Treatment Market Analysis

According to Cognitive Market Research, the global Canine Arthritis Treatment market size was estimated at USD 2685.2 Million, out of which Asia Pacific held the market of more than 23% of the global revenue with a market size of USD 617.60 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2030 due to an expanding pet care industry and increased awareness of pet health. The dominating segment includes pharmaceuticals such as anti-inflammatory drugs and joint supplements. With the rise in pet ownership and a shift towards responsible pet healthcare, there is a growing demand for effective arthritis treatments. Veterinary clinics and pet healthcare providers are crucial in promoting these treatments. In conclusion, the Asia Pacific canine arthritis treatment market reflects a convergence of a burgeoning pet-loving culture and a focus on animal welfare. The dominating pharmaceutical segment underscores the importance of accessible and quality treatments for addressing the health needs of companion animals in the Region.

• According to Cognitive Market Research, the China Canine Arthritis Treatment market size was valued at USD 277.92 million in 2023 and is projected to grow at a CAGR of 6.0% during the forecast period. This is due to a rising pet ownership culture, increased awareness about pet health, and a growing elderly canine population, fostering demand for effective and advanced arthritis treatment options.
• The India Canine Arthritis Treatment market had a market share of USD 74.11 million in 2023 and is projected to grow at a CAGR of 8.3% during the forecast period. This is due to a rising pet ownership culture, increased awareness of pet healthcare, and the growing prevalence of arthritis in dogs, stimulating demand for effective veterinary treatments and therapies.
• The Japan Canine Arthritis Treatment market is projected to grow at a CAGR of 5.0% during the forecast period, with a market size of USD 85.23 million in 2023.
• The South Korean Canine Arthritis Treatment market is projected to grow at a CAGR of 5.6% during the forecast period, with a market size of USD 61.76 million in 2023.
• The Australian Canine Arthritis Treatment market is projected to grow at a CAGR of 6.2% during the forecast period, with a market size of USD 32.11 million in 2023.
• The Southeast Asia Canine Arthritis Treatment market is projected to grow at a CAGR of 7.5% during the forecast period, with a market size of USD 42.61 million in 2023.
• The Rest of the Asia Pacific Canine Arthritis Treatment market is projected to grow at a CAGR of 6.3% during the forecast period, with a market size of USD 43.85 million in 2023.

South America Canine Arthritis Treatment Market Analysis

According to Cognitive Market Research, the global Canine Arthritis Treatment market size was estimated at USD 2685.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 134.26 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2023 to 2030 due to an increased focus on pet health and the rising pet ownership trend. Overview-wise, Latin America's growing urbanization and disposable income contribute to the market's expansion. The dominating segment in the Latin American market includes pharmaceutical treatments and supplements for canine arthritis, reflecting the Region's inclination toward comprehensive pet care solutions. As the awareness of pet well-being increases, the demand for effective arthritis treatments rises. In conclusion, the Latin American canine arthritis treatment market signifies a blend of pet care awareness and market potential. The dominating pharmaceutical and supplement segment underscores the Region's commitment to addressing canine health issues, presenting growth opportunities for manufacturers and service providers.

• According to Cognitive Market Research, the Brazil Canine Arthritis Treatment market was valued at USD 57.46 million in 2023 and is projected to grow at a CAGR of 4.5% during the forecast period. This is due to a rising awareness of pet health, an increasing pet population, and the demand for advanced veterinary care, contributing to the growth of arthritis treatment solutions for canines. 
• The Argentina Canine Arthritis Treatment market had a market share of USD 22.56 million in 2023 and is projected to grow at a CAGR of 4.8% during the forecast period. This is due to a rising awareness of pet healthcare, a growing pet ownership culture, and an increasing incidence of arthritis in dogs, fostering demand for effective treatment solutions. 
• The Colombia Canine Arthritis Treatment market is projected to grow at a CAGR of 3.7% during the forecast period, with a market size of USD 11.95 million in 2023.
• The Peru Canine Arthritis Treatment market is projected to grow at a CAGR of 4.1% during the forecast period, with a market size of USD 11.01 million in 2023.
• The Chile Canine Arthritis Treatment market is projected to grow at a CAGR of 4.2% during the forecast period, with a market size of USD 9.67 million in 2023.
• The Rest of the Latin America Canine Arthritis Treatment market is projected to grow at a CAGR of 3.0% during the forecast period, with a market size of USD 21.62 million in 2023.

Middle East Canine Arthritis Treatment Market Analysis

According to Cognitive Market Research, the global Canine Arthritis Treatment market size was estimated at USD 2685.2 Million, out of which the Middle East and Africa are the major markets of more than 2% of the global revenue with a market size of USD 53.70 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030 due to growing pet care industry and an aging canine population contribute to market expansion. The dominating segment in the MEA market includes pharmaceuticals and nutraceuticals targeting arthritis relief in dogs. As pet owners seek advanced treatment options, pharmaceutical interventions, and specialized canine diets gain prominence. In conclusion, the MEA canine arthritis treatment market signifies the Region's commitment to pet well-being. The dominating segment underscores the demand for effective and specialized solutions, presenting growth opportunities for manufacturers addressing the evolving needs of pet owners in the MEA market.

• According to Cognitive Market Research, the GCC Countries Canine Arthritis Treatment market was valued at USD 22.99 million in 2023 and is projected to grow at a CAGR of 5.0% during the forecast period. This is due to a rising pet ownership culture, an aging canine population, increased awareness of pet healthcare, and a growing demand for effective arthritis management solutions. 
• The South African Canine Arthritis Treatment market had a market share of USD 8.49 million in 2023 and is projected to grow at a CAGR of 5.2% during the forecast period. This is due to a rising awareness of pet health, an increasing pet population, and a growing emphasis on veterinary care, contributing to the demand for effective arthritis treatments for dogs. 
• The Egypt Canine Arthritis Treatment market is projected to grow at a CAGR of 4.5% during the forecast period, with a market size of USD 5.64 million in 2023.
• The Turkey Canine Arthritis Treatment market is projected to grow at a CAGR of 3.7% during the forecast period, with a market size of USD 4.62 million in 2023.
• The Nigeria Canine Arthritis Treatment market is projected to grow at a CAGR of 3.3% during the forecast period, with a market size of USD 5.64 million in 2023.

Canine Arthritis Treatment Market Analysis

Canine Arthritis Treatment Type Segment Analysis

In the surgery segment, arthroscopy and joint replacement procedures are key interventions for managing canine arthritis. Surgical interventions aim to alleviate pain and improve joint function in affected dogs, particularly in severe cases.

On the pharmaceutical front, drugs play a crucial role in canine arthritis treatment. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to reduce inflammation and pain. Disease-modifying osteoarthritis drugs (DMOADs) aim to slow the progression of arthritis, providing long-term benefits. Additionally, analgesics and corticosteroids may be employed for symptomatic relief.

• Surgery
• Drugs
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Canine Arthritis Treatment Industry. Request a Free Sample PDF!

Canine Arthritis Treatment Application Segment Analysis

The oral route involves administering medications through the mouth, commonly in tablets, capsules, or liquids. This approach offers pet owners convenience and allows at-home administration, enhancing treatment compliance.

On the other hand, the parenteral route involves administering medications directly into the body, bypassing the digestive system. This method typically includes injections, either subcutaneously or intramuscularly. Parenteral administration can be advantageous in cases where direct and fast absorption is crucial or when the dog may have difficulty taking oral medications.

• Oral
• Parenteral
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Canine Arthritis Treatment Treatment Segment Analysis

NSAIDs are a primary segment, encompassing widely used drugs like carprofen and meloxicam. These medications help manage arthritis symptoms by reducing inflammation, alleviating pain, and improving dog joint mobility. 

Opioids constitute another essential segment, often prescribed for more severe cases where NSAIDs alone may not provide sufficient pain relief. Opioids such as tramadol are employed to manage moderate to severe pain associated with canine arthritis.

• Non-steroidal anti-inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

Canine Arthritis Treatment Distribution Channel Segment Analysis

Hospital Pharmacy channels are critical in the market, serving as essential access points for veterinary treatments. These outlets provide a range of canine arthritis medications, ensuring immediate availability for prescribed therapies. The Hospital Pharmacy segment is vital for severe cases requiring specialized care and immediate medical attention.

On the other hand, the Retail Pharmacy segment caters to broader accessibility for pet owners. Retail Pharmacies, often located in local communities, offer convenience for purchasing canine arthritis treatments, supplements, and medications. This channel is essential for routine medications, preventive care, and less severe cases of arthritis, where owners may seek over-the-counter solutions.

• Hospital Pharmacy
• Retail Pharmacy
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion